Mirabella Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,069
Closed -$421K 309
2024
Q2
$421K Sell
3,069
-23,075
-88% -$3.08M 0.03% 282
2024
Q1
$3.59M Buy
+26,144
New +$3.57M 0.26% 68
2023
Q2
Sell
-24,297
Closed -$3.14M 564
2023
Q1
$3.14M Buy
+24,297
New +$3.18M 0.48% 55
2021
Q1
Sell
-26,090
Closed -$3.95M 346
2020
Q4
$3.95M Buy
+26,090
New +$3.73M 0.49% 81

Other funds holding IBB

Mirabella Financial Services's IBB Position: Q3 2024 in Review

Mirabella Financial Services sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 3,069 shares — an estimated $421K sold.

Mirabella Financial Services first reported a position in IBB in Q4 2020 and held it in 4 quarters. The position peaked at $3.95M in Q4 2020. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • Mirabella Financial Services reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • Mirabella Financial Services sold 3,069 iShares Biotechnology ETF shares in Q3 2024, an estimated $421K.
  • Mirabella Financial Services first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 4 quarters.
  • Mirabella Financial Services's iShares Biotechnology ETF position peaked at $3.95M in Q4 2020.
  • 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on Mirabella Financial Services's 13F filing for Q3 2024, filed 13 Nov 2024.